TD Cowen raises target for HCA Healthcare stock from USD 431 to USD 460

Published on 10/15/2026 at 09:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Results are set for October 27, 2026 after Q2 revenue reached USD 20.23 billion. HCA Healthcare stock costs EUR 421.20 on October 15, 2026.

Recent company milestones

TD Cowen raised its HCA Healthcare target to USD 460 on October 12, 2026.
HCA Healthcare reported USD 20.23 billion of second-quarter revenue on July 24, 2026.
HCA Healthcare stock traded at EUR 421.20 at 9:36 a.m. CEST at Lang & Schwarz on October 15, 2026.

Draufsicht auf Aktienzertifikat, ISIN-Karte US40412C1018, Stethoskop und Medizinequipment auf Marmor — HCA Healthcare US40412C1018 Flatlay mit Aktienzertifikat ISIN Karte Stethoskop und branchentypischen medizinischen Utensilien, Illustration mit AI erstellt.

HCA Healthcare (ISIN US40412C1018) was trading at EUR 421.20 at Lang & Schwarz on October 15, 2026 at 9:36 a.m. CEST. The latest analyst action came from TD Cowen, which raised its target from USD 431 to USD 460 on October 12, 2026, according to TradingView.

Analyst target moves higher

TD Cowen maintained a Buy rating and set the USD 460 target, while its note highlighted HCA Healthcare's hospital network and outpatient expansion. The target was tied to an October 9, 2026 US closing price of USD 451.09 in the analyst coverage reported by TradingView.

For context, HCA Healthcare's second-quarter 2026 revenue reached USD 20.23 billion, while diluted earnings per share were USD 7.62. The same quarter generated USD 3.067 billion of operating profit and USD 1.699 billion of net income attributable to common shareholders, according to the standardized financial figures for the period ended June 30, 2026.

Three dated stock developments

On July 24, 2026, HCA Healthcare reported second-quarter revenue of USD 20.23 billion and earnings per share of USD 7.59, compared with a USD 7.56 consensus estimate, as reported by MarketBeat. On September 30, 2026, HCA Healthcare announced an earnings call for its third quarter, with the event scheduled for October 27, 2026, through its investor-relations page. On October 12, 2026, TD Cowen raised its target to USD 460 while retaining its Buy rating, according to TradingView.

What date comes next?

HCA Healthcare's next substantiated reporting event is the third-quarter 2026 earnings call on October 27, 2026, at 10:00 a.m. Eastern, according to HCA Healthcare. The upcoming report will give investors a new operating comparison against the USD 20.23 billion of revenue recorded in the second quarter.

Stock price and valuation context

HCA Healthcare's primary listing is on the NYSE under ticker HCA. The US quote was USD 470.44 on October 14, 2026, while the 52-week range was USD 330.00 to USD 556.52 and market capitalization was USD 101.9 billion.

HCA Healthcare was trading at EUR 421.20 at Lang & Schwarz on October 15, 2026 at 9:36 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of HCA Healthcare stock.